Skip to content

Role of Gnaphalium Polycephalum in patients with Sciatica aged 40-60 years

Utility of Gnaphalium Polycephalum in adults aged 40-60 years with Sciatica: A prospective interventional study using Sciatica Bothersomeness Index (SBI) and Sciatica Frequency Index (SFI) - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/11/097825
Enrollment
50
Registered
2025-11-21
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M543- Sciatica

Interventions

Intervention1: Gnaphalium Polycephalum: Gnaphalium Polycephalum Homoeopathic Medicine with potency as per patient susceptibility and repetition every 15 days will be given. Control Intervention1: NOT

Sponsors

Parul University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with positive Straight Leg Raising Test (SLRT). 2. Patients from both the sexes between the age of 40yrs-60yrs having pain will be included. 3. Patients willing to give consent for the study.

Exclusion criteria

Exclusion criteria: 1. Patients with other systemic illness or congenital deformities. 2. Cases of pregnant woman or lactating woman 3. Patient taking any other mode of treatment. 4. Cases with irregular follow up will be excluded.

Design outcomes

Primary

MeasureTime frame
Marked Improvement Moderate Improvement Mild Improvement Status Quo Any increase in Sciatica Bothersomeness Index and Sciatica Frequency Index score from the baseline score will be counted as worse.Timepoint: 3 months

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Vivekbhai Meghjibhai Bhojani

Jawaharlal Nehru Homoeopathic Medical College and Hospital, Parul University

gaurav.sharma18479@paruluniversity.ac.in9824372731

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026